secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0000885725-23-000028
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific shareholders elect all nine director nominees at 2023 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with support from majority of votes cast; broker non-votes 40.5M.
- Advisory vote on named executive officer compensation approved: 1.13B for, 90.4M against.
- Stockholders recommended one-year frequency for future say-on-pay votes; Board adopted annual frequency.
- Ratification of Ernst & Young as independent auditor for FY 2023 approved: 1.18B for, 87.5M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000028/0000885725-23-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000028/bsx-20230504.htm
  HTML page:      https://secwatch.observer/filing/0000885725-23-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer